1 nd should be further tested in a prospective
multicenter study.
2 d Methods: 16 patients were included in this
multicenter study.
3 them with matched untransplanted peers in a
multicenter study.
4 ing warrants confirmation with a prospective
multicenter study.
5 department (ED) in a prospective diagnostic
multicenter study.
6 not previously been analyzed using a large,
multicenter study.
7 results of a larger randomized, controlled,
multicenter study.
8 fter allogeneic HCT within this prospective,
multicenter study.
9 Prospective,
multicenter study.
10 and 3 Months) is a prospective, single-arm,
multicenter study.
11 hods: Sixteen patients were included in this
multicenter study.
12 label, randomized, active-controlled, 3-arm,
multicenter study.
13 obtained at all sites for this prospective,
multicenter study.
14 this assay was investigated previously in a
multicenter study.
15 ival, but has not been evaluated in a large,
multicenter study.
16 s an open-label, randomized, parallel-group,
multicenter study.
17 srael Deaconess Medical Center approved this
multicenter study.
18 n individual bone lesions from patients in a
multicenter study.
19 r 10 weeks in a double-blind, parallel-group
multicenter study.
20 dosis and its association with survival in a
multicenter study.
21 logies were evaluated in this retrospective,
multicenter study.
22 dy are encouraging and warrant a prospective
multicenter study.
23 versus no early coronary angiography in this
multicenter study.
24 We enrolled 159 patients in a prospective
multicenter study.
25 and without dysplasia or EAC, enrolled in a
multicenter study.
26 were prospectively enrolled in a diagnostic
multicenter study.
27 e included in this prospective observational
multicenter study.
28 mapping for AT diagnosis in a randomized and
multicenter study.
29 from measurement variability, especially in
multicenter studies.
30 e-blind, placebo-controlled, parallel group,
multicenter studies.
31 rt C (PN-3682-011 and -012) were open-label,
multicenter studies.
32 escriptive, cross-sectional, nonintervention
multicenter studies.
33 international studies, and between single vs
multicenter studies.
34 o large multi-instrument, multimodality, and
multicenter studies.
35 ch as PSMA-617, which is also the subject of
multicenter studies.
36 encouraging further investigation, including
multicenter studies.
37 In a
multicenter study,
113 healthy participants over 40 year
38 In this
multicenter study,
1182 patients hospitalized for CAP we
39 this phase II, randomized placebo-controlled
multicenter study,
20 patients with active disease enrol
40 In a prospective
multicenter study,
30 consecutive patients with severe d
41 In this
multicenter study,
43 consecutive choroideremia patients
42 In this prospective
multicenter study,
55 subjects with or at high risk for
43 In this
multicenter study,
94 infants with TSC without seizure h
44 re enrolled in a prospective, observational,
multicenter study across the United States.
45 This
multicenter study addressed the course of disease for ea
46 is German prospective, randomized controlled
multicenter study,
adult patients with moderate-to-sever
47 In an open-label,
multicenter study,
adults >/=65 years of age, vaccinated
48 This retrospective European
multicenter study aimed to assess the sustained virologi
49 This
multicenter study aimed to evaluate the clinical and pro
50 This
multicenter study analyzed Nocardia spp., including extr
51 This cross-sectional retrospective
multicenter study analyzed the clinical and genetic char
52 Comparisons to severe asthma
multicenter studies and available registries showed data
53 y of future research outputs, can facilitate
multicenter studies and meta-analyses of pooled data, an
54 lerotic disease (ICAD) in a population-based
multicenter study and report examination and reader reli
55 sis, but the accuracy of this technique in a
multicenter study and the association of Tc 99m PYP myoc
56 nthracycline treatment were enrolled in this
multicenter study and underwent a standardized functiona
57 e enrolled onto a prospective North American
multicenter study and were observed at least up to 12 mo
58 HIPAA-compliant institutional board approved
multicenter study,
and all participants provided written
59 (n = 992) were enrolled in this case-control
multicenter study,
and serum cytokine levels were measur
60 Although well-designed clinical trials and
multicenter studies are needed to determine the effects
61 Multicenter studies are needed to replicate these findin
62 impact recruitment to the workforce; larger,
multicenter studies are needed to validate these results
63 Further
multicenter studies are needed using harmonized UFP meas
64 f the design and results from 2 longitudinal
multicenter studies are presented.
65 ts enrolled in the available studies, larger
multicenter studies are required to validate these findi
66 This
multicenter study assembled genome-wide genotypic and ph
67 This
multicenter study assessed the performance of the cobas
68 This prospective Australian
multicenter study assessed whether (68)Ga-PSMA PET/CT im
69 We present a
multicenter study assessing the occurrence and significa
70 An international,
multicenter study at 4 large academic centers was conduc
71 A nationwide
multicenter study based on the Italian Primary Immunodef
72 Patient-based TTV may be preferred for
multicenter studies because its repeatability was both h
73 This international
multicenter study by the Upper GI International Robotic
74 This
multicenter study collected blood samples from children
75 This
multicenter study compared the investigational-use-only
76 We performed a
multicenter study comparing 13 commonly used scRNA-seq a
77 a phase 3, double-blind, active-controlled,
multicenter study conducted at 39 outpatient referral ce
78 ants: In an ongoing prospective, diagnostic,
multicenter study conducted at 9 emergency departments,
79 spective, population-based, cross-sectional,
multicenter study conducted between 2011 and 2013.
80 In this open label,
multicenter study conducted over 1-year follow-up, we ra
81 This
multicenter study confirms that SEE is a strong predicto
82 This
multicenter study confirms that the Working Formulation
83 tory computed tomography images from a large
multicenter study (
COPDGene) of current and former smoke
84 ine of 680 subjects participating in a large
multicenter study (
COPDGene) over approximately 5 years.
85 Conclusion This
multicenter study demonstrated early and progressive inv
86 There are no large
multicenter studies describing the frequency and analges
87 ing account of potential confounders and the
multicenter study design.
88 (NCT03595176) was a prospective, single-arm
multicenter study designed for regulatory approval of co
89 t observational, prospective, multinational,
multicenter study determined the minimal important diffe
90 Researchers in a recent
multicenter study developed and validated a novel progno
91 In this
multicenter study,
donor kidney histology assessment dur
92 We conducted a retrospective large-scale
multicenter study encompassing over 300 million patients
93 Methods: This prospective
multicenter study enrolled 260 men between 2015 and 2017
94 This
multicenter study enrolled 56 patients with DM and 51 co
95 This
multicenter study enrolled 983 consecutive patients (mea
96 ed a secondary analysis of an international,
multicenter study enrolling adult patients coming from t
97 We performed a
multicenter study enrolling patients referred to 4 demen
98 This
multicenter study evaluated cefoxitin disk diffusion for
99 A prospective, split-mouth,
multicenter study evaluated scaling and root planing (SR
100 This
multicenter study evaluated the clinical performance cha
101 andomized, double-blind, placebo-controlled,
multicenter study evaluated the effects of intravenous h
102 This randomized, double-blind,
multicenter study evaluated the effects of tumor necrosi
103 This
multicenter study evaluated the noninferiority of a 0/1-
104 This
multicenter study evaluated the outcome of DAIR in relat
105 This
multicenter study evaluated the outcome of DAIR in relat
106 This was a prospective,
multicenter study evaluating all curative antibiotic the
107 This is the first
multicenter study evaluating this treatment approach.
108 This retrospective
multicenter study examined patients who resumed ICI ther
109 In this longitudinal
multicenter study exhaled breath samples were taken from
110 -PCI (An Open-Label, Randomized, Controlled,
Multicenter Study Exploring Two Treatment Strategies of
111 Thus, there is a necessity for prospective
multicenter studies focusing on the prognostic role of c
112 A retrospective
multicenter study from 3 French renal transplant centers
113 lant prognosis, we conducted a retrospective
multicenter study from a large French nationwide registr
114 isolates collected during the Global Enteric
Multicenter Study from seven study sites in Asia and Afr
115 The Global Enteric
Multicenter Study (
GEMS) has described the incidence, ae
116 and hygiene access across the Global Enteric
Multicenter Study (
GEMS) sites in Africa and South Asia
117 The Global Enteric
Multicenter Study (
GEMS) was a 3-year case-control study
118 ss causes of diarrhoea in the Global Enteric
Multicenter Study (
GEMS).
119 However, no large
multicenter study has focused on the relationship betwee
120 UFP) on health is still inconsistent and few
multicenter studies have been conducted so far especiall
121 This
multicenter study identifies insights into the risk fact
122 Conclusions This
multicenter study illustrates the potential utility of p
123 ary syndrome, but have not been validated in
multicenter studies in a cohort that allows comparisons.
124 (68)Ga-PSMA-11 is currently the subject of
multicenter studies in different countries.
125 contributed to by a growing number of other
multicenter studies in which imaging is embedded.
126 Conclusion In this prospective,
multicenter study in a selection of patients with ER-pos
127 This is a prospective
multicenter study in children ages 3 months to 5 years w
128 In a prospective
multicenter study in France, we evaluated GBS colonizati
129 retrospective, noninterventional, national,
multicenter study in patients from the Spanish Hepa-C re
130 and Methods In a prospective, observational,
multicenter study in patients younger than 70 years old
131 CRADLE was a 36-month
multicenter study in pediatric (>=1 to <18 years) kidney
132 This
multicenter study in six Dutch centers included consecut
133 Patients with known AF were enrolled in a
multicenter study in Switzerland.
134 We conducted a
multicenter study in the United States of 112 adult LT r
135 ubsequent cardiac testing in a retrospective
multicenter study in the United States.
136 This
multicenter study included 29 consecutive patients with
137 This
multicenter study included 575 adult patients with TOF (
138 This
multicenter study included 7 tertiary care neuro-ophthal
139 This international
multicenter study included 8 comprehensive stroke center
140 This
multicenter study included 911 patients from 3 LT center
141 This
multicenter study included consecutive adult patients wi
142 Materials and Methods This retrospective
multicenter study included consecutive patients who pres
143 This retrospective
multicenter study included patient data collected from J
144 Methods: This retrospective
multicenter study included patients who had cCR after nC
145 This
multicenter study included sites in the United Kingdom a
146 This prospective, observational,
multicenter study includes data from 503 individuals wit
147 evaluate the performance of this method in a
multicenter study including 16 teaching hospitals in the
148 A retrospective
multicenter study including 18 HNF1B patients receiving
149 This was a
multicenter study including 4949 patients who underwent
150 pproved this retrospective, HIPAA-compliant,
multicenter study;
informed consent was waived.
151 This prospective, observational,
multicenter study initially screened 3,410 patients (2,0
152 The present
multicenter study investigated whether equivalent outcom
153 ith [18F]-Florbetapir (INDIA-FBP) Study is a
multicenter study involving 18 AD evaluation units from
154 Here we report a large-scale
multicenter study involving training and validation coho
155 A definitive
multicenter study is now warranted in this population to
156 This
multicenter study is observational and cross-sectional a
157 easured sensitivity of MR biomarkers in this
multicenter study may be critically important to future
158 This
multicenter study measured PENK in 1,908 patients with a
159 2008 and 2012, a prospective, observational,
multicenter study (
MERCURY II) recruited 279 patients wi
160 thma, and 16 nonatopic healthy subjects in a
multicenter study (
NCT01537133).
161 We conducted a prospective,
multicenter study (
NEXT-in-CML) to assess the frequency
162 Conclusions and Relevance: This
multicenter study noted significant differences in the q
163 An international,
multicenter study (
NTR 1310), the VICI-trial was perform
164 cancer, no prospective, quality-controlled,
multicenter studies of this strategy have been conducted
165 The present retrospective
multicenter study of (177)Lu-PSMA-617 RLT demonstrates f
166 This was a prospective
multicenter study of 113 patients with isolated burn inj
167 We conducted a
multicenter study of 138 patients with immune checkpoint
168 We conducted a prospective
multicenter study of 172 living liver donors.
169 This was a multinational,
multicenter study of 182 CSU patients.
170 This large,
multicenter study of 24-hour IOP control with BBFC met i
171 In this observational cross-sectional
multicenter study of 340 patients, we evaluated the impa
172 This is a
multicenter study of 6 hydrophilic acrylic IOLs (Lentis
173 We performed a retrospective
multicenter study of 712 patients with CGD who underwent
174 This
multicenter study of 8 EDs in the United States enrolled
175 A
multicenter study of adult patients with candidemia was
176 This was an observational
multicenter study of all consecutive adult patients diag
177 A retrospective, interventional,
multicenter study of all patients with conjunctival myxo
178 This was a
multicenter study of all pediatric patients with AML wit
179 Patients from the
multicenter Study of an Implantable Device for Lowering
180 Patients from the
multicenter Study of an Implantable Device for Lowering
181 This international
multicenter study of CASQ2-CPVT redefines its heritabili
182 A retrospective
multicenter study of characteristics and outcomes of 318
183 uation, and Education) registry to conduct a
multicenter study of consecutive patients who underwent
184 In a prospective
multicenter study of consecutive patients with suspected
185 We analyzed data from a
multicenter study of endoscopic therapy to identify fact
186 Iron Overload Screening (HEIRS) Study was a
multicenter study of ethnically diverse participants tha
187 ients and Methods We performed a prospective
multicenter study of FDG-PET/CT scanning 12 weeks after
188 These observational data from this first
multicenter study of HCR suggest that there is no signif
189 Prospective
multicenter study of HIV-1-infected, antiretroviral-naiv
190 In a large
multicenter study of infants hospitalized with bronchiol
191 The MOMENTUM 3 study (
Multicenter Study of MagLev Technology in Patients Under
192 The MOMENTUM 3 trial (
Multicenter Study of MagLev Technology in Patients Under
193 rformed a 24-week, randomized, double-blind,
multicenter study of nemolizumab (10, 30, and 90 mg) sub
194 , <1000 g) cases with IC and controls from a
multicenter study of neonatal candidiasis enrolled from
195 ting Stents) was a large-scale, prospective,
multicenter study of patients undergoing drug-eluting st
196 gn, Setting, and Participants: Retrospective
multicenter study of patients who underwent resection fo
197 This was a retrospective
multicenter study of patients with HCC-HCV listed for LT
198 We conducted a retrospective,
multicenter study of patients with SARS-CoV-2 who were a
199 In this prospective
multicenter study of post-operative patients with RVOT o
200 dolescents from the IMAGEN study (a European
multicenter study of reinforcement sensitivity in adoles
201 Data were collected by a large
multicenter study of sporadic retinoblastoma in which pa
202 A prospective
multicenter study of surface and intracortical depth ele
203 We performed an open-label, prospective,
multicenter study of the effectiveness and tolerance of
204 A
multicenter study of the investigational Virtuo system (
205 Registry or the REALISM (Real World Expanded
Multicenter Study of the MitraClip System) Continued-Acc
206 , and the REALISM Continued Access Registry (
Multicenter Study of the MitraClip System).
207 METHODS AND This is a retrospective,
multicenter study of the short- and intermediate-term ou
208 We performed a single-arm,
multicenter study of treatment-naive adults with HCV gen
209 We performed a prospective,
multicenter study of two-dimensional (2D) MRE in childre
210 This study analyzed data from ITAMY (ITalian
multicenter study on Acute MYocarditis) and evaluated CM
211 We performed a retrospective
multicenter study on bronchoalveolar lavage fluid (BALF)
212 S undergoing isolated CABG from the European
Multicenter Study on Coronary Artery Bypass Grafting (E-
213 y assess these links, we performed the first
multicenter study on emotion recognition and interocepti
214 This is the first randomized, controlled
multicenter study on patient education in adult AD.
215 ed in 147 patients included in a prospective
multicenter study on the impact of tumor clearance evalu
216 t significant differences between single and
multicenter studies,
or according to CVE adjudication av
217 In this large,
multicenter study,
patients who received cefazolin had a
218 In this
multicenter study,
patients with confirmed genetic diagn
219 In this
multicenter study,
patients with refractory large B-cell
220 Despite being a
multicenter study,
plasma p-tau181 demonstrated high dia
221 This
multicenter study population included 1 eye of both 930
222 This large
multicenter study provides evidence of an association be
223 The trial was an international,
multicenter study randomizing 2 heart teams to make a tr
224 aphy-Negative Dense Breasts is a prospective
multicenter study recruiting asymptomatic women with mam
225 When planning
multicenter studies,
researchers should make contingency
226 This
multicenter study reviews all bilateral lung transplanta
227 Further large
multicenter studies sharing the same imaging protocols a
228 Future prospective
multicenter studies should validate their role as a diag
229 This large,
multicenter study shows that improved biochemical, patho
230 Conclusion This
multicenter study shows that the diagnostic performance
231 This
multicenter study sought to determine Z scores for commo
232 This
multicenter study sought to evaluate the accuracy of the
233 This
multicenter study sought to prospectively evaluate a dra
234 This
multicenter study sought to test and validate the progno
235 In this prospective,
multicenter study,
surgical inpatients from four German
236 This
multicenter study surveyed 21 US program directors in ge
237 Conclusions and Relevance: In this
multicenter study,
Tc 99m PYP cardiac imaging conferred
238 uble-blind, placebo-controlled international
multicenter study testing the effect of early IV beta-bl
239 SIMPLIFY and D3FEAT are international,
multicenter studies that recruited participants with rec
240 The BICRHOME study was a prospective,
multicenter study that enrolled 312 cirrhotic patients w
241 s was a phase III, randomized, double-blind,
multicenter study that evaluated the efficacy and safety
242 We performed a cross-sectional,
multicenter study that included 344 liver transplant rec
243 Imaging in Acute Stroke) is an observational
multicenter study that prospectively recruited patients
244 In this
multicenter study the LFA assay from BALF demonstrated g
245 In this
multicenter study,
the BD Max xEBP showed a high correla
246 In our
multicenter study,
the incidence of germline mutations i
247 In this European
multicenter study,
the sensitivity and specificity of th
248 In this large, independently adjudicated,
multicenter study,
the stent fracture rate was low and n
249 In
multicenter studies,
tight glycemic control targeting a
250 e compared CDI assays across two prospective
multicenter studies to set a cutoff for the Clarity assa
251 Prospective, large-scale
multicenter studies to validate the result are warranted
252 We conducted a
multicenter study to address the prognosis of this condi
253 We conducted a
multicenter study to ascertain the diagnostic value of b
254 These data support a larger, longer,
multicenter study to determine the safety and efficacy o
255 We conducted a
multicenter study to develop a blood-based molecular bio
256 We performed a prospective,
multicenter study to evaluate OCT findings in patients w
257 We conducted a prospective,
multicenter study to evaluate the performance of stool a
258 treated mUC were enrolled in this phase I/II
multicenter study to receive NIVO3, NIVO3+IPI1, or NIVO1
259 This
multicenter study,
to our knowledge, is the first phase
260 Multicenter studies using a common nutritional screening
261 findings merit the current efforts of large
multicenter studies using standardized sampling, shared
262 Cross-sectional
multicenter study using data from the Brazilian Metaboli
263 This
multicenter study validated single-center evidence that
264 This HIPAA-compliant prospective
multicenter study was approved by institutional review b
265 This prospective, single-arm,
multicenter study was conducted from November 2012 to Ja
266 A retrospective
multicenter study was conducted in French Guiana from 1
267 Methods A prospective international
multicenter study was conducted on 186 consecutive FD pa
268 A
multicenter study was conducted on patients with low rec
269 A prospective
multicenter study was conducted to assess the immunogeni
270 1, 2014, to December 31, 2016, a prospective
multicenter study was conducted with echocardiography in
271 The
multicenter study was performed at tertiary care centers
272 A retrospective
multicenter study was performed on patients with a docum
273 A
multicenter study was performed to establish the perform
274 An observational, prospective,
multicenter study was performed.
275 A retrospective
multicenter study was performed.
276 The aim of this
multicenter study was to define the role of antibiotics
277 s in children enrolled in the Global Enteric
Multicenter Study was used to investigate the genomic di
278 In this uncontrolled, phase 1-2,
multicenter study,
we administered oral acalabrutinib to
279 Using data from the Global Enteric
Multicenter Study,
we assessed whether acute malnutritio
280 In an institutional review board-approved
multicenter study,
we carried out a retrospective analys
281 In this
multicenter study,
we compared the performance of the Si
282 In this
multicenter study,
we describe the characteristics and o
283 In this prospective
multicenter study,
we evaluated CMV-CMI every 2 weeks fr
284 In this phase 2
multicenter study,
we evaluated the incorporation of aut
285 In this
multicenter study,
we followed HIV-positive adults who h
286 In this
multicenter study,
we found that several machine learnin
287 In this retrospective,
multicenter study,
we have investigated the role of surv
288 In this
multicenter study,
we included 37 patients with multiref
289 In a
multicenter study,
we prospectively recruited 55 patient
290 In a
multicenter study,
we randomized 200 patients with large
291 In this
multicenter study,
we retrospectively analyzed a cohort
292 In the present
multicenter study,
we used structural magnetic resonance
293 We found that
multicenter studies were necessary to capture treatment
294 We propose novel
multicenter studies,
which are needed to achieve this go
295 ethics committee approved this retrospective
multicenter study with a waiver of informed consent.
296 itiated, randomized, clinical, international
multicenter study with blinded assessment of the outcome
297 randomized, sham-controlled, parallel-group,
multicenter study with blinded assessments.
298 Within this setting of a prospective,
multicenter study with uniform GVHD prophylaxis, conditi
299 Retrospective
multicenter study within the Paediatric Tuberculosis Net
300 In a prospective
multicenter study without controls, a transcatheter pace